Higher dose of semaglutide increases weight loss, metabolic benefits Tripling the standard amount could safely treat patients with greater weight reduction goals, clinical trial led by UTSW researcher shows Tripling the standard dose of semaglutide, a popular drug prescribed to treat obesity, led to significantly greater weight loss and associated metabolic benefits without increased risk of serious side effects, a multicenter clinical trial led by a UT Southwestern Medical Center researcher shows
Peptides can help with muscle growth and fat loss when they support recovery, lean mass maintenance, appetite patterns, sleep quality, or training consistency
219 JacobS.PoegglerB.WeishauptJ
[52] evaluated the cytotoxic effects of aqueous and methanolic extracts of both fresh and black garlic on various cancer cell lines, including A549 (lung), HuH-7 (liver), MCF-7 (breast), and HCT-116 (colon)
More targets has, so far, meant more weight lost in trials